Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis

por Turina, Maureen C, Yeremenko, Nataliya, Paramarta, Jacqueline E, De Rycke, Leen, Baeten, Dominique
Publicado 2014

A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis

por Paramarta, Jacqueline E., Turina, Maureen C., Noordenbos, Troy, Heijda, Tanja F., Blijdorp, Iris C., Yeremenko, Nataliya, Baeten, Dominique
Publicado 2016

A psychometric analysis of outcome measures in peripheral spondyloarthritis

por Turina, Maureen C, Ramiro, Sofia, Baeten, Dominique L, Mease, Philip, Paramarta, Jacqueline E, Song, In-Ho, Pangan, Aileen L, Landewé, Robert
Publicado 2016

Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort

por Turina, Maureen C, Yeremenko, Nataliya, van Gaalen, Floris, van Oosterhout, Maikel, Berg, Inger J, Ramonda, Ramona, Lebre, Cristina (M C), Landewé, Robert, Baeten, Dominique
Publicado 2017

Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages

por Vogelpoel, Lisa T. C., Hansen, Ivo S., Rispens, Theo, Muller, Femke J. M., van Capel, Toni M. M., Turina, Maureen C., Vos, Joost B., Baeten, Dominique L. P., Kapsenberg, Martien L., de Jong, Esther C., den Dunnen, Jeroen
Publicado 2014